Drugs / 95-6-22
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00001507 Background | Jul 1996 → Jun 1998 | breast neoplasm, metastatic neoplasm | National Cancer Institute (NCI) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 95-6-22 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00001507 ↗ |
| Modality | Monoclonal antibody | “Monoclonal Antibody 95-6-22” NCT00001507 ↗ |